Business EconomyPosted at: Nov 9 2024 9:29PM


Aurobindo pharma Q2FY25 reports consolidated net profit of Rs 817 crore

Hyderabad, Nov 9 (UNI) Aurobindo Pharma, an integrated global pharmaceutical company, reported a consolidated net profit of Rs 817 crore for the quarter that ended September 30, 2024, up 8.6 percent from Rs 752 crore a year ago.
Consolidated Revenue from Operations during the quarter increased by 8 percent Y-o-Y to Rs 7,796 crore with growth across the businesses, Hyderabad-based pharma company said in a release here on Saturday.
In Q2FY24, the company’s revenues stood at Rs 7,219 crore
Operational Performance (Consolidated), the company said that its revenues from US formulations (excluding Puerto Rico) increased by 4.3 percent YoY to Rs 3,530 crore (USD 421 million) while from Europe formulations increased by 19 percent YoY to Rs 2,105 crore (EUR 229 million) and growth Markets revenue up by 44 percent YoY to Rs 812 crores (USD 97 million).
The Pharma Company spent Rs 410 crore, 5.3 percent on revenues on Research & Development (R&D including depreciation).
Commenting on the Company’s performance, Aurobindo Vice-Chairman and Managing Director K. Nithyananda Reddy, said: "We are pleased with the continued growth in revenues across our key business areas this quarter, reflecting the resilience of our diversified portfolio. While profitability saw a slight dip, primarily due to the transient nature of certain business activities, our underlying performance remains strong. With a solid foundation and ongoing operational improvements, we are confident of maintaining our growth trajectory and achieving our strategic objectives for the year."
The Company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals, and active pharmaceutical ingredients globally in over 150 countries.
The company has 29 manufacturing and packaging facilities that are approved by leading regulatory agencies including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA.
UNI KNR BD
Please log in to get detailed story.
Tags: #Aurobindo pharma Q2FY25 reports consolidated net profit of Rs 817 crore
More News

Singareni’s 800 MW Ultra Supercritical Thermal Power Project coming up in Mancherial

09 Nov 2025 | 8:30 PM

Hyderabad, Nov 9 (UNI) The foundation stone for the upcoming 800 MW Ultra Supercritical Thermal Power Project at the existing Singareni Thermal Power Plant (STPP) premises in Jaipur, Mancherial district of Telangana, is expected to be laid soon.
Singareni Collieries Company Ltd (SCCL) Chairman and Managing Director N Balaram, who visited STPP, instructed the plant Executive Director and General Managers to ensure that all arrangements are in place for the foundation stone laying, by the state government.

see more..

Foreign investors resume selling in Nov after brief pause in Oct

09 Nov 2025 | 5:54 PM

New Delhi, Nov 9 (UNI) The foreign portfolio investors have resumed selling after a brief pause in October pulling out a net Rs 12,569 crore from Indian equities thus far in November.

see more..

Foreign exchange reserves fall by USD 21 87 billion in three weeks

09 Nov 2025 | 3:45 PM

Mumbai, Nov 9 (UNI) India’s foreign exchange reserves fell by USD 5.623 billion to USD 689.733 billion during the week ended October 31, marking a cumulative decline of USD 21.869 billion over the past three weeks.

see more..

Singareni launches free accidental insurance scheme to its employees & contract workers

09 Nov 2025 | 1:57 AM

Hyderabad, Nov 8 (UNI) Singareni Collieries Company Limited (SCCL) Chairman and Managing Director N. Balram today stated that the free accident insurance scheme, launched for the first time in the country for Singareni employees and contract workers with the cooperation of government and private sector banks as per the directions of the State Government, has become a model for the entire nation.
He said that both the Central and State Governments are now taking steps to implement this scheme in their respective organizations.

see more..

Adani Kutch Copper inks deal with caravel for Australian project

09 Nov 2025 | 12:18 AM

Mumbai, Nov 7 (UNI) Adani Group's Kutch Copper Ltd has officially announced that it has signed a non-binding memorandum of understanding (MoU) with Australia's Caravel Minerals Ltd to collaborate on the latter's copper project in Western Australia. According to the deal, Adani-owned Kutch Copper will have the first rights to participate at the project-level or as direct equity investments during the MoU term.

see more..